⌘K

Home/Filings/4/0001493152-22-032564

4//SEC Filing

Bernards Rene 4

Accession 0001493152-22-032564

CIK 0001335105other

View on SEC.gov Company Profile

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 7:44 PM ET

Size

4.4 KB

Accession

0001493152-22-032564

Insider Transaction Report

Form 4

Period: 2022-11-14

LIXTE BIOTECHNOLOGY HOLDINGS, INC.LIXT

Director

Transactions

Purchase
Common Stock
2022-11-14$0.53/sh+52,500$27,825→ 125,000 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

CIK 0001335105

Entity typeother

Related Parties

1

filerCIK 0001939159

Filing Metadata

Form type: 4
Filed: Nov 14, 7:00 PM ET
Accepted: Nov 15, 7:44 PM ET
Size: 4.4 KB

View on SEC.gov